|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.92 USD | -0.10% |
|
+0.35% | +80.28% |
| Market Cap | 8.9B 7.72B 7.23B 6.62B 12.49B 848B 12.65B 84.62B 33.21B 424B 33.42B 32.69B 1,410B | P/E 2026 * |
-17.8x | P/E 2027 * | -20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 7.87B 6.83B 6.39B 5.85B 11.04B 749B 11.18B 74.78B 29.35B 374B 29.53B 28.89B 1,246B | EV / Sales 2026 * |
134x | EV / Sales 2027 * | 46.7x |
| Free-Float |
98.25% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Crinetics Pharmaceuticals, Inc.
| 1 day | -0.10% | ||
| 1 week | +0.35% | ||
| Current month | +0.48% | ||
| 1 month | +99.67% | ||
| 3 months | +101.20% | ||
| 6 months | +85.34% | ||
| Current year | +80.28% |
| 1 week | 83.62 |  | 84.08 |
| 1 month | 83.44 | | 84.08 |
| Current year | 32.3 | | 84.08 |
| 1 year | 25.83 | | 84.08 |
| 3 years | 15.76 | | 84.08 |
| 5 years | 15.23 | | 84.08 |
| 10 years | 10.63 | | 84.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 61 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/2/26 | Sell | Director | -3,000 | 0.0028% | ||
| 3/12/26 | Sell | Director | 5,000 | 0.0048% | ||
| 2/23/26 | Free | Chief Financial Officer | 82,000 | 0.0871% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.10% | +0.35% | +194.15% | +348.77% | 8.9B | |
| -3.25% | +13.72% | +52.49% | +88.86% | 62.92B | |
| +2.47% | +3.68% | +34.14% | +74.71% | 54.32B | |
| -1.07% | -1.79% | -18.07% | -14.36% | 22.91B | |
| +33.86% | +30.60% | +19.14% | +502.77% | 28.73B | |
| +10.49% | +17.91% | +52.17% | +4.17% | 21.65B | |
| +6.41% | +8.31% | +39.16% | -20.78% | 17.76B | |
| -3.37% | +25.85% | +213.21% | +369.13% | 16.47B | |
| +6.40% | +11.51% | +34.94% | +681.88% | 15.48B | |
| -7.94% | -6.74% | +38.42% | +157.52% | 13.12B | |
| Average | +4.35% | +7.31% | +65.98% | +219.27% | 26.23B | |
| Weighted average by Cap. | +4.39% | +8.33% | +51.11% | +172.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.81M 51.04M 47.79M 43.72M 82.53M 5.6B 83.61M 559M 219M 2.8B 221M 216M 9.32B | 172M 149M 140M 128M 242M 16.4B 245M 1.64B 642M 8.2B 646M 632M 27.28B |
| Net income | -516M -448M -420M -384M -725M -49.2B -734M -4.91B -1.93B -24.58B -1.94B -1.9B -81.82B | -473M -410M -384M -351M -663M -45.02B -672M -4.49B -1.76B -22.49B -1.77B -1.74B -74.86B |
| Net Debt | -1.04B -898M -841M -769M -1.45B -98.6B -1.47B -9.84B -3.86B -49.26B -3.89B -3.8B -164B | -865M -751M -703M -643M -1.21B -82.42B -1.23B -8.22B -3.23B -41.18B -3.25B -3.18B -137B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | US$83.92 | -0.10% | 2,096,262 |
| 26-08-05 | US$84.00 | +0.17% | 2,866,831 |
| 26-08-04 | US$83.86 | +0.12% | 2,725,922 |
| 26-08-03 | US$83.76 | +0.29% | 1,745,072 |
| 26-07-31 | US$83.52 | -0.13% | 1,863,939 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
